Ibudilast was originally developed in Japan 20 years ago as a treatment for asthma.
异丁司特最初是在日本20年前作为一种治疗哮喘。
The two California-based companies are running clinical trials of a drug called ibudilast.
两个总部设在加州的公司正在临床试验的药物称为异丁司特。
Conclusion: Ibudilast su stained-release capsule is an effective agent for treatment of asthma or chronic asthmatic bronchitis.
结论：异丁司特缓释胶囊是一种安全有效的治疗支气管哮喘和慢性喘息性支气管炎的药物。
Ibudilast, an inhibitor of glial activation and cyclic nucleotide phosphodiesterases, has shown potential in the treatment of neuropathic pain and opioid withdrawal.
异丁司特作为一种神经胶质激活和环核苷酸磷酸二酯酶抑制剂，已被显示有治疗神经性疼痛和阿片脱瘾的可能性。
Ibudilast, an inhibitor of glial activation and cyclic nucleotide phosphodiesterases, has shown potential in the treatment of neuropathic pain and opioid withdrawal.
异丁司特作为一种神经胶质激活和环核苷酸磷酸二酯酶抑制剂，已被显示有治疗神经性疼痛和阿片脱瘾的可能性。
应用推荐